Based on SEC filing data. A biotech corporation in San Antonio has raised $1.5M through a convertible note in Series B funding, with current revenues between $1M and $1M. The company is in early commercialization stages with a capital structure that allows flexible debt-to-equity conversion.
Get notified the moment BI02 MEDICAL, INC. files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.